Carregant...
Fitxers
Tipus de document
ArticleVersió
Versió publicadaData de publicació
Llicència de publicació
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/109602
Effect of Maraviroc intensification on HIV-1-specific T cell immunity in recently HIV-1-infected individuals
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
BACKGROUND: The effect of maraviroc on the maintenance and the function of HIV-1-specific T cell responses remains unknown. METHODS: Subjects recently infected with HIV-1 were randomized to receive anti-retroviral treatment with or without maraviroc intensification for 48 weeks, and were monitored up to week 60. PBMC and in vitro-expanded T cells were tested for responses to the entire HIV proteome by ELISpot analyses. Intracellular cytokine staining assays were conducted to monitor the (poly)-functionality of HIV-1-specific T cells. Analyses were performed at baseline and week 24 after treatment start, and at week 60 (3 months after maraviroc discontinuation). RESULTS: Maraviroc intensification was associated with a slower decay of virus-specific T cell responses over time compared to the non-intensified regimen in both direct ex-vivo as well as in in-vitro expanded cells. The effector function profiles of virus-specific CD8⁺ T cells were indistinguishable between the two arms and did not change over time between the groups. CONCLUSIONS: Maraviroc did not negatively impact any of the measured parameters, but was rather associated with a prolonged maintenance of HIV-1-specific T cell responses. Maraviroc, in addition to its original effect as viral entry inhibitor, may provide an additional benefit on the maintenance of virus-specific T cells which may be especially important for future viral eradication strategies.
Matèries (anglès)
Citació
Col·leccions
Citació
KAWANA-TACHIKAWA, Ai, LLIBRE, Josep maría, BRAVO, Isabel, ESCRIG, Roser, MOTHE, Beatriz, PUIG, Jordi, PUERTAS CASTRO, Ma. carmen, MARTÍNEZ PICADO, Francisco javier, BLANCO, Julià, MANZARDO, Christian, MIRÓ MEDA, José m. (josé maría), IWAMOTO, Aikichi, POZNIAK, Anton l., GATELL, José m., CLOTET, Bonaventura, BRANDER, Christian. Effect of Maraviroc intensification on HIV-1-specific T cell immunity in recently HIV-1-infected individuals. _PLoS One_. 2014. Vol. 9, núm. 1, pàgs. e87334. [consulta: 25 de gener de 2026]. ISSN: 1932-6203. [Disponible a: https://hdl.handle.net/2445/109602]